| Takeda Pharma AG - Elvanse 40 mg, Hartkapseln | | 63023 | | 05 | | Elvanse 40 mg | | Hartkapseln | | N06BA12 | | | | 16.11.2016 | | |
| | Composition | | lisdexamfetamini dimesilas 40 mg corresp. dexamfetaminum 11.9 mg, cellulosum microcristallinum, carmellosum natricum conexum, magnesii stearas, Kapselhülle: gelatina, E 133, E 171, E 172 (nigrum), E 172 (flavum), Drucktinte: lacca, propylenglycolum, kalii hydroxidum, E 172 (nigrum), pro capsula corresp. natrium 0.3336 mg. | | Packungsbestandteile | | Capsules | | | | | | | | Principe actif | Concentr. |
|---|
| | 40 mg correspond 11.9 mg |
| | BAG: Principe actif | Concentr. |
|---|
| | 40 mg |
| | | | Agents auxilliaires | | informations additionels |
|---|
| | | | | | | | | | | | | | | | | | | color. | | | | color. | | | | color. | | Gelatina | | Kapselhülle | | | | | | | | Drucktinte | | | | | | Propylenglycol | | |
| |
| | numéro d'emballage | Taille des présentations | PEF | PP | Cat. | LS | Hors commerce (MedRef) |
|---|
| 005 | 30 | 93.29 | 117.85 | A+ | LS | Non |
|
|
